Apr 5, 2019 | Cost Savings, Prescription
The ongoing movement to reduce prescription drug spending focuses primarily on the cost factor. But as Shannon Brownlee and Judith Garber contend in a Stat opinion piece, overprescribing of drugs also carries financial and health risks. “Between 2000 and 2012,...
Feb 23, 2019 | Cost Savings, MedBen Rx, Prescription, Rebates, Specialty Drugs, Transparency
A recent Wall Street Journal editorial warns that government efforts to address prescription drug prices could produce undesirable consequences… and it’s why MedBen Rx believes that market-driven solutions are the preferable method to reducing consumer costs. As...
Feb 22, 2019 | Announcements, Claims Management, Cost Savings, Third party administration
MedBen takes pride in its expert claim examiners – indeed, in our most recent audit our team received a payment accuracy rating of 99.9%. But when we receive a claim that merits further inspection, our advanced surveillance system lends a hand. Electronic surveillance...
Jan 27, 2019 | Cost Savings, MedBen Rx, Prescription
A recent high-profile disagreement between Walmart and pharmacy benefits manager (PBM) CVS Caremark exemplifies the friction between pharmacies and PBMs about prescription pricing… and the power that PBMs possess to influence drug costs. MedBen Rx was designed...
Jan 25, 2019 | Claims Management, Cost Savings, Reference-Based Pricing
MedBen claims management uses multiple measures to ensure that your plan pays the proper price for health care services, but at the core is our team of experienced claim examiners. To cite one example, a plan member of a MedBen client underwent robotic hernia repair...
Jan 13, 2019 | Cost Savings, Discounts, MedBen Rx, Prescription, Rebates, Research
New year, higher drug prices. According to The Wall Street Journal, a representative analysis of major pharmaceutical companies found that the prices of their brand name and generic drugs have risen by an average of 6.3% in 2019 – modest compared to previous years,...
